Dr. Earl A. Zimmerman, MD

Expert Publications

• High-field magnetic resonance imaging of brain iron: birth of a biomarker?
• 1H MR spectroscopy using TE averaged PRESS: a more sensitive technique to detect neurodegeneration associated with Alzheimer's disease.
• Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain.
• Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism.
• Ideal management of diabetes mellitus and dementia: walking a tightrope between hyperglycemia and hypoglycemia.
• Improved myo-inositol detection through Carr-Purcell PRESS: a tool for more sensitive mild cognitive impairment diagnosis.
• Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and neuropsychological status among older adults in New York.
• Exergaming and older adult cognition: a cluster randomized clinical trial.
• Raman spectroscopy of blood serum for Alzheimer's disease diagnostics: specificity relative to other types of dementia.
• Anti-Ri-associated paraneoplastic brainstem cerebellar syndrome with coexisting limbic encephalitis in a patient with mixed large cell neuroendocrine lung carcinoma.

Clinical Trials

• 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

Media Releases

Get to know Neurologist Dr. Earl A. Zimmerman, who serves patients in Albany, New York.

A New York-based neurologist, Dr. Zimmerman is the Founder and Director of the Alzheimer’s Center at Albany Medical Center, and serves as a Professor of Neurology at Albany Medical College. He specializes in behavioral neurology and the diagnosis and treatment of dementia.

As the Director of an Alzheimer’s Disease Center of Excellence for the Capital Region of New York, his major focus is the education of physicians in the diagnosis and care of patients with Alzheimer’s disease and dementia. His current research is focused on new diagnostic methods for early detection and measures for effectiveness of new treatments for Alzheimer’s disease and other neurological disorders of aging.

In regards to his educational background, Dr. Zimmerman received his undergraduate degree from Franklin and Marshall College, and his medical degree from the University of Pennsylvania. He received his clinical and research training at Columbia Presbyterian Medical Center, where he became professor of neurology and well known for his research in neuroendocrinology.

As a testament to his success, the doctor is board-certified in neurology by the American Board of Psychiatry and Neurology (ABPN). The ABPN is a not-for-profit corporation dedicated to serving the professions of psychiatry and neurology.

Moreover, he is board-certified in internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

In 1985, Dr. Zimmerman became Professor and Chairman of Neurology at Oregon Health and Sciences University in Portland and founded the federally funded Oregon Alzheimer’s Disease Research Center.

Neurology is a branch of medicine dealing with disorders of the nervous system. Neurologists are licensed medical specialists who diagnose and treat disorders that affect the brain, spinal cord, nerves, and muscles of patients. They examine a patient’s mental and physical status, conduct medical tests and scans, and evaluate the results to diagnose and treat the patient.

Recommended Articles

• New Research Disproves Link Between Alzheimer's and Heartburn Drugs

  Previous studies have found an association between common heartburn medications and an increased risk of AD. However, more recent studies have reached other conclusions.A group of researchers from Germany found that proton pump inhibitors (PPIs), including commonly used medications such as Nexium,...

• Montell Williams's Journey with Multiple Sclerosis and Medical Marijuana

  Sometimes it seems like multiple sclerosis has a mind all of its own. Patients can never be entirely sure when symptoms are going to flare up and cause severe problems, and they can never be quite sure when those symptoms will subside. On top of that, multiple sclerosis can be difficult to diagnose...

• Understanding Social Anxiety Disorder in Parkinson's Disease

  It is natural to have some kind of emotional distress, anxiety, and sadness when diagnosed with Parkinson’s disease. But SAD is not just about being sad, it is being anxious and fearful of participating in social activities. SAD is an abbreviation for social anxiety disorder also known as social...

• Parkinson's: Tips From a Professional Occupational Therapist

  Once the diagnosis of Parkinson's has been dropped on a person, it is natural to feel devastated. Modern medicine can help a lot but still, it cannot stop the progression of the disease. However, with lifestyle changes a person can delay the progression of symptoms, and continue to live...

• Muscular Dystrophy: Combining Brain-Computer Interfaces and Assistive Technologies

  With the development of modern computers and networks, assistive technologies (AT) for people with disabilities have changed a lot. Not only can one control the devices through the voice, indeed, most of the devices and appliances can be connected to the voice activation services. So one can change...

• World War II Veteran's Touching Serenade for His Wife of 75 Years

  Edward and Betty’s Story94-year old pianist, Edward Hardy, may have lost several of his memories and skills due to dementia, but he definitely did not lose his ability to play the piano. For his wife Betty, there could not have been a better way to ring in their 75th anniversary than serenading...